Company intelligence / Profile preview

FITNOTES

Ownership: Private
Development stage: Commercial

Overview

FIT Biotech developed the GTU® platform for gene therapy and DNA vaccines, targeting cancer, infectious diseases like HIV and tuberculosis, and animal health. No recent clinical results are available; the company was active with financing events up to 2018 but has not reported new developments since then.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Gene therapyDNA vaccine
Industry: Biotech

Partnerships

Bracknor InvestmentABO Group

Beyond the preview

Go deeper on FITNOTES.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FITNOTES.

Explore the full profile